Overview
LARS Ligament Augmentation & Reconstruction System offers a broad range of synthetic ligaments for use in a wide variety of applications – from anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) reconstruction, to ankle and shoulder repairs.
• Enhanced stability1,2
• Rapid recovery1,2
• Early mobilisation1,2
• No tissue harvesting
• No further loss of
proprioception
First introduced in 1992, LARS ligaments are gaining popularity as an internal fixation device providing a scaffold for natural tissue in-growth. LARS has been developed to avoid the problems faced with synthetic ligaments in the past by incorporating a patented ‘pre-twisted parallel fibre’ concept. Using a design which mimics the native anatomic ligament fibres – intra-articular longitudinal fibres resist fatigue and allow fibroblastic in-growth, whilst extra-articular woven fibres provide strength and resistance to elongation.
• Patented pre-twisted
parallel fibre concept
• Progressive
manufacturing
technology
• Refined surgical
indications
LARS has been successfully used for more than 15 years in a wide variety of patients – from members of the general public requiring a fast return to daily activities through to elite athletes at the top of their game. LARS ligaments are used in countries such as the UK, France, Germany, Canada and Australia.Regulatory approval has been granted for LARS in all countries where it has been sought. To date, over 330 surgeons have successfully implanted more than 4,500 ligaments in Australia alone. This number continues to grow as the potential of LARS becomes more widely recognised and understood.
References:
1. Zhong-tang Liu & Xian-long Zhang & Yao Jiang & Bing-Fang Zeng. Four-strand hamstring tendon autograft versus LARS artificial ligament for anterior cruciate ligament reconstruction IntOrthop (SICOT) - 2009
2. Li B, Wen Y, Wu H, Qian Q, Wu Y, Lin X. Arthroscopic single-bundle posterior cruciate ligament reconstruction: retrospective review of hamstring tendon graft versus LARS artificial ligament. IntOrthop. 2009 Aug;33(4):991-6.
Important: LARS is not available or cleared for distribution in all international markets. For more details, please contact your local subsidiary or distributor by visiting the Corin worldwide section of the Corin Group corporate website. The information and guidance provided here is general in nature and should not be considered as medical advice in any way. You should always seek detailed advice from a qualified medical practitioner.
